InsiderTrades

Form 4 for FAST Fastenal

Accepted 2026-08-17 11:19:05 ET · period of report 2026-08-13 · accession 0002043506-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-08-17 11:19 2026-08-13 FAST Papenfuss Donnalee Kathleen EVP-Strategy, Communication M - OptEx $18.23 +9,258 7,894 New +$168.7K
DM 2026-08-17 11:19 2026-08-13 FAST Papenfuss Donnalee Kathleen EVP-Strategy, Communication S - Sale+OE $51.39 -9,258 0 -100% -$475.8K
DM 2026-08-17 11:19 2026-08-13 FAST Papenfuss Donnalee Kathleen EVP-Strategy, Communication M - OptEx $0.00 -9,258 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-13 M A 1,364 $13.75 1,364 D — —
2 Common Common Stock 2026-08-13 S D 1,364 $51.42 0 D — —
3 Common Common Stock 2026-08-13 M A 7,894 $19.00 7,894 D — —
4 Common Common Stock 2026-08-13 S D 7,894 $51.38 0 D — —
5 Derivative Employee Stock Option (Right to Buy) 2026-08-13 M D 1,364 $0.00 0 D $13.75 · — to 2027-12-31 1,364 Common Stock (F2) The option will vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two years after the relevant vesting period, and the remainder vesting and becoming exercisable proportionately each year thereafter.
6 Derivative Employee Stock Option (Right to Buy) 2026-08-13 M D 7,894 $0.00 0 D $19.00 · — to 2029-12-31 7,894 Common Stcck (F3) The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025. (F3) The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025. (F4) The option will vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately on each anniversary of the grant date. (F3) The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025.